Pandemic stress associated with higher inflammation in Parkinson’s
Stress may be linked to higher levels of inflammation in people with Parkinson’s disease, according to a new analysis…
Articles by Marisa Wexler, MS
Experimental vaccine shows early signs of benefit in Parkinson’s
ACI-7104, an experimental vaccine being tested in people with early-stage Parkinson’s disease, has been generally well tolerated and…
Scientists find brain models for Parkinson’s need refinement
Researchers creating a map of the developing human brain found that methods used to grow brain cells lost in…
FDA to hear plan for buntanetap as Parkinson’s dementia treatment
Annovis Bio has scheduled a January meeting with the U.S. Food and Drug Administration (FDA) to discuss buntanetap…
Scientists create first visualization of tiny Parkinson’s protein clumps
For the first time, scientists have managed to visualize tiny protein clumps in the brain that are thought to trigger…
Scientists caution on some experimental Parkinson’s therapies
Some experimental therapies for Parkinson’s disease designed to improve the function of mitochondria may inadvertently damage them instead.
Overactive dopamine cells may drive Parkinson’s brain damage
Brain damage in Parkinson’s disease may be driven in part by certain nerve cells working too hard, causing them…
Hemoglobin discovery may offer strategy for Parkinson’s treatment
Hemoglobin — a protein best known for carrying oxygen in the bloodstream — has an under-recognized role in protecting brain…
Parkinson’s advocacy groups call for ‘robustly funded, collaborative NIH’
A trio of prominent Parkinson’s disease advocacy groups are calling on the U.S. federal government to provide strong funding…
Levels of fat molecules altered in brains of Parkinson’s patients: Study
People with Parkinson’s disease have altered levels of certain fat molecules, known as lipids, in their brains, and this…